Cellular biology of human intimal hyperplastic stenosis.
Restenosis after angioplasty and vascular surgery remains a major unsolved clinical problem. Vascular smooth muscle cell (VSMC) hyperplasia is an invariable response, but in 20-50% of cases proceeds to compromise the vessel lumen. We sought to identify cellular characteristics of human VSMC which are associated with restenosis. Human VSMC were grown from 135 samples of vascular tissue derived from patients undergoing primary cardiovascular surgery and revision surgery for restenosis. Cells derived from normal vein and artery, atherosclerotic plaques and from stenotic lesions were studied for successful proliferation in cell culture. Furthermore, growth rates were measured in response to 15% foetal calf serum +/- inhibition with heparin (100 micrograms/ml). Significantly fewer cells from atherosclerotic plaques progress to the third passage in cell culture than those derived from stenoses and controls (p < 0.001, Chi square) and growth rates after the third passage could not be studied in these cells. Of cells that progress to this stage, growth rates do not differ between stenosis-derived and normal cells under standard conditions. VSMC from mature atherosclerotic plaques may have undergone senescent changes. Stenosis-derived cells do not grow more rapidly than normal cells, but are significantly less sensitive to heparin (p < 0.001, Mann-Witney test), which is a major physiological inhibitor of VSMC growth. Differences in biological characteristics of human VSMC, observed in cell culture, may provide important insights into human vascular disease.
Chan
P
P
Department of Vascular Surgery, St Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine, London, U.K.
Munro
E
E
Patel
M
M
Betteridge
L
L
Schachter
M
M
Sever
P
P
Wolfe
J
J
D000199:Actins / Q000502:physiology; D000800:Angioplasty, Balloon; D001161:Arteriosclerosis / Q000473:pathology / Q000601:surgery*; D002455:Cell Division / Q000502:physiology*; D002465:Cell Movement / Q000502:physiology; D002478:Cells, Cultured; D005352:Fibromuscular Dysplasia / Q000473:pathology* / Q000601:surgery; D005455:Fluorescent Antibody Technique; D006083:Graft Occlusion, Vascular / Q000473:pathology / Q000601:surgery; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000473:pathology; D011183:Postoperative Complications / Q000473:pathology* / Q000601:surgery; D012008:Recurrence; D012086:Reoperation; D017539:Tunica Intima / Q000473:pathology*; D014841:von Willebrand Factor / Q000502:physiology
D000199:Actins; D014841:von Willebrand Factor